In addition to its cellular homeostasis function, autophagy is emerging as a central component of antimicrobial host defense against diverse infections. To counteract this mechanism, many pathogens have evolved to evade, subvert, or exploit autophagy. Here, we report that autophagy proteins (i.e., Beclin-1, Atg4B, Atg5, and Atg12) are proviral factors required for translation of incoming hepatitis C virus (HCV) RNA and, thereby, for initiation of HCV replication, but they are not required once infection is established. These results illustrate a previously unappreciated role for autophagy in the establishment of a viral infection and they suggest that different host factors regulate the translation of incoming viral genome and translation of progeny HCV RNA once replication is established.
In addition to its cellular homeostasis function, autophagy is emerging as a central component of antimicrobial host defense against diverse infections. To counteract this mechanism, many pathogens have evolved to evade, subvert, or exploit autophagy. Here, we report that autophagy proteins (i.e., Beclin-1, Atg4B, Atg5, and Atg12) are proviral factors required for translation of incoming hepatitis C virus (HCV) RNA and, thereby, for initiation of HCV replication, but they are not required once infection is established. These results illustrate a previously unappreciated role for autophagy in the establishment of a viral infection and they suggest that different host factors regulate the translation of incoming viral genome and translation of progeny HCV RNA once replication is established.
flaviviridae ͉ autophagosome ͉ LC3 ͉ ATG ͉ translation H CV infection is a leading cause of chronic liver disease world-wide. With 180 million persistently infected people, chronic hepatitis C infection, which induces end stage liver diseases, such as liver cirrhosis and hepatocellular carcinoma (HCC), represents a major public health problem of high socioeconomic impact (1) . However, treatment options for chronic hepatitis C are limited and a vaccine against HCV is not available. Thus, efforts to elucidate the details of the host-virus relationship during HCV infection are needed to develop efficient therapeutic strategies against this major human pathogen.
HCV is an enveloped, positive strand RNA virus in the Flaviviridae family. The HCV genome is approximately 9.6 kb in length and consists of a single ORF flanked by untranslated regions (UTR) (2) . Translation of the single ORF is driven by an internal ribosomal entry site (IRES) sequence present within the 5ЈUTR. The resulting polyprotein is processed by cellular and viral proteases into the structural proteins (core, E1, and E2) and the nonstructural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B) (2) . HCV NS3 to NS5B proteins are necessary and sufficient to establish membrane-bound replication complexes that catalyze RNA replication (2) .
Autophagy is an intracellular degradation process in which cytoplasmic components, including organelles, are directed to the lysosome by a membrane-mediated process (3) . More than 31 autophagy-related genes (ATG) whose products regulate autophagy have been identified, primarily through yeast genetics, and several have mammalian counterparts (3) . They regulate distinct aspects of autophagic vesicle formation and maturation, including the assembly of an isolation membrane around a portion of cytoplasm, completion of a double-membranesurrounded autophagosome, and lysosomal fusion with degradation of its contents (3). Importantly, many studies demonstrate that autophagy is activated upon viral or bacterial infection (4). In Sindbis virus, tobacco mosaic virus, herpes simplex virus type 1 (HSV-1) and several bacterial infections, autophagy may have a protective function by restricting intracellular pathogen replication or by ensuring the survival of infected and/or uninfected cells (4) . In this regard, autophagy serves as an innate host defense mechanism, and some viruses and bacteria produce virulence factors that counteract these antimicrobial processes (4-7). Conversely, certain viruses, for example, mouse hepatitis virus, poliovirus, coxsackievirus and dengue virus, actually exploit the elements of the autophagy system for their replication (8) (9) (10) (11) (12) .
In this study, by manipulating the expression and function of key autophagy regulators, we show that these proteins are required for productive HCV infection. Moreover, by dissecting the individual steps of HCV infection, we demonstrate that autophagy is required for translation and/or delivery of incoming viral RNA to the translation apparatus.
Results

Enhanced Autophagic Vesicle Content in HCV-Infected Cells.
A hallmark of autophagy induction is lipidation of the microtubuleassociate protein 1 light chain 3 (LC3) (13) . A series of covalent transfers leads to phosphatidylethanolamine (PE) conjugation to LC3, termed LC3-II, which becomes membrane-associated and participates in autophagosome formation (3, 14, 15) . To determine whether JFH-1-HCV infection regulates autophagy, we examined the conversion of endogenous LC3 to LC3 II. The intensity of LC3-II band was increased in HCV infected cells relative to uninfected (mock) cells (Fig. 1A) . In addition, comigration of LC3-II in infected cells and in cells treated with autophagy inducers, for example, the proteasome inhibitor acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN) and the ER stress inducer thapsigargin (Tg) (16, 17) , confirmed that the band detected was authentic LC3-II. Another hallmark of autophagy is the redistribution of LC3 from a diffuse cytoplasmic localization to a characteristic punctate cytoplasmic pattern reflecting the recruitment of LC3 to autophagic vesicles (13, 14) . Indeed, in cells transfected with a GFP-tagged LC3 expression vector (LC3-GFP), LC3-GFP redistribution into discrete dots was markedly increased by HCV infection (Fig. 1B and C) , further confirming the accumulation of autophagic vesicles upon HCV infection.
The Autophagy Machinery Is Required for the HCV Life Cycle. To determine whether the autophagy machinery performs an antiviral or proviral function during HCV infection, we monitored the effect of shRNA-mediated knock-down of key autophagy proteins on the establishment of HCV infection. We targeted Beclin-1 and Atg4B, because Beclin-1, in complex with Vps34, the class III phosphatidylinositol-3-kinase [PI(3)K] promotes formation of autophagic vesicles (18) , and Atg4B is a cysteineprotease essential for LC3 lipidation during autophagosome formation and de-lipidation for recycling after autophagosome maturation (14, 15, (19) (20) (21) (22) . As shown in Fig. 2A , Beclin-1 and Atg4B expression was strongly inhibited in Huh-7 cells by lentivirus-based vector-mediated shRNA technology. As expected, the induction of autophagy by thapsigargin (Tg) was markedly decreased in these cells, as measured by the frequency The authors declare no conflict of interest. 1 To whom correspondence should be addressed. E-mail: fchisari@scripps.edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/ 0907344106/DCSupplemental. of cells containing punctate LC3-GFP (Fig. S1 ), confirming the reduction of autophagic vesicle formation that has been previously described for other cell types (23, 24) .
Next, Atg4B-and Beclin-1-deficient cells were infected with HCV at low multiplicity of infection (MOI) and HCV expansion was measured over the next 6 days by determining extracellular infectious viral titers. This analysis revealed that, HCV expansion was suppressed up to 100-fold in Atg4B-deficient cells and almost completely abolished in Beclin-1-deficient cells as compared to control cells (Fig. 2B) . The intracellular HCV RNA content paralleled extracellular HCV infectivity with reductions of up to 10,000-fold in Atg4B-and Beclin-1-down-regulated cells (Fig. 2C) . To confirm and extend these observations, we also tested the effect of shRNA-mediated inhibition of Atg12, a critical component of a ubiquitin-like conjugation system that enables elongation of the autophagosome (3). As expected, because LC3 lipidation depends on Atg5 and its conjugation with Atg12 (25, 26) , both LC3-II species and the induced punctate GFP-LC3 distribution were reduced in Atg12 shRNA-treated Huh-7 cells as compared to control cells (Fig. S2 A) . Importantly, HCV expansion was greatly reduced in Atg12-deficient cells (Fig. S2B) , reinforcing the requirement of autophagy machinery proteins for efficient HCV infection. Consistent with these observations, ectopic expression of a dominant negative Atg5 mutant (Atg5 K130R ) that is defective for conjugation with Atg12 and suppresses autophagic vesicle formation (25, 27 ) also inhibited HCV infection (Fig. S3) .
Collectively, these results demonstrate that key proteins responsible for different steps of autophagic vesicle formation are required for initiation of HCV infection in Huh-7 cells and thus represent proviral factors for HCV.
The Autophagy Machinery Is Not Required for HCV Particle Entry or
Secretion. To identify the autophagy-dependent step(s) in the HCV life cycle, we performed single cycle infections in Beclin-1-, Atg4B-, and Atg12-deficient and control cells. Intracellular and extracellular (i.e., secreted) infectious particle production were reduced to a similar degree in Beclin-1-, Atg4B-, and Atg12-deficient cells, (Fig. 3A and Fig. S2C ), indicating that, in contrast to the role of autophagy proteins in poliovirus particle release (8) , the autophagy machinery is not required for HCV particle secretion. Moreover, accumulation of intracellular HCV RNA was also significantly reduced in autophagy protein-downregulated cells (Fig. 3A and Fig. S2C ), suggesting that the autophagy machinery is required for either virus entry, RNA translation or replication.
To examine the dependence of HCV entry on autophagy, we studied the impact of shRNA-mediated inhibition of autophagy protein expression on HCV pseudoparticle (HCVpp) entry into Huh7 cells (28) . Autophagy protein-down-regulated and control cells were infected with HCVpp that contain envelope glycoproteins from the JFH-1 (genotype 2a) and H77 (genotype 1a) strains of HCV. As shown in Fig. 3B and Fig. S2D , HCVpp entry was comparable in autophagy protein-deficient and control cells ( Fig. 3B and Fig. S2D ). Collectively, these results suggest that the autophagy machinery is required for HCV infection at a postentry step, most likely HCV RNA translation and/or replication.
The Autophagy Machinery Is Required for HCV Replicon Replication.
To determine whether the autophagy machinery modulates HCV RNA translation and/or replication, we examined the ability of autophagy protein-down-regulated cells to support replication of an HCV subgenomic replicon. Identical amounts of JFH-1 subgenomic replicon RNA containing the neomycin marker gene (neo/SGR) were introduced into autophagy protein-down-regulated and control cells. Replicon-replicating cells were selected for neomycin resistance as described previously (29) . As shown in Fig. 4A and Fig. S4A , down-regulation of Beclin-1, Atg4B, and Atg12 strongly suppressed JFH-1 replicon replication despite comparable RNA transfection efficiency (Fig. S5A ) and cell viability as determined by trypan blue staining. Similar results were obtained using a Con1 (genotype 1b) subgenomic replicon (Fig. 4A, Fig. S4A, and Fig. S5B ). To rule out the possibility of nonspecific effects on neomycin sensitivity by suppression of the autophagy machinery, we confirmed these findings by using a subgenomic reporter replicon containing the renilla luciferase gene (Rluc/SGR). While the transfection efficiency was comparable in all cell populations (Fig. S5C) , the Rluc activity was reduced by up to 50-fold at all time points posttransfection in Beclin-1, Atg4B, and Atg12-deficient cells (Fig. 4B and Fig. S4B ). Collectively, these results indicated that autophagy machinery proteins are required for RNA translation and/or replication.
Next, we asked whether autophagosomes might facilitate the tethering of HCV replication complex proteins to cellular membranes, a process that is known to be required for HCV replication (2). Consistent with a previous report using the H77 Translation of replication-deficient Rluc/SGR RNAs. Intracellular RNA levels and Rluc activity of replication deficient Rluc/SGR were determined at 6 h posttransfection. Rluc activities are statistically reduced in autophagy protein deficient cells compared to shRNA GFP expressing cells (P values Ͻ0.05 from paired Student's t test). In parallel transfections, Rluc activity expressed from pRL-TK plasmid (irrelevant-Rluc activity) was determined. For each independent experiment, Rluc activity was normalized to cell density and expressed as a percentage of that determined in control cells (mean Ϯ SD; n ϭ 3).
strain of HCV (30), we did not observe any colocalization of HCV JFH1 proteins involved in viral replication (NS4A/4B and NS5A) with LC3-GFP in infected cells (Fig. S6) , in the absence or presence of the vesicle acidification inhibitor Bafilomycin A1 (Fig. S7) . These results suggest that the autophagy machinery is most likely not required to maintain an active HCV replication complex.
The Autophagy Machinery Is Required for Translation and/or Delivery
of Incoming Viral RNA to the Translation Apparatus. Interestingly, Rluc activity was compromised in autophagy protein-deficient cells Ͼ3-fold already at 5 h posttransfection, suggesting that autophagy proteins might play a role in HCV RNA translation initiation. To specifically monitor viral translation, we used a replication-defective Rluc/SGR construct that contains an inactivation mutation (GDD-to-GND) in the active site of the viral polymerase (NS5B), and we analyzed Rluc activity expressed from the HCV IRES, as previously described (31) . While the level of intracellular Rluc/SGR RNA was comparable in autophagy protein-deficient and control cells (Fig. 4C and Fig. S4C ), HCV IRES-dependent translation measured by Rluc activity was strongly reduced in Beclin-1, Atg4B, and Atg12-downregulated cells as compared to control and GFP shRNAexpressing cells (Fig. 4C and Fig. S4C ). Reduced Rluc expression was not due to a general effect on ectopic gene translation efficiency or protein stability, since Rluc activity derived from cap-dependent translation of a RNA polymerase II transcribed RNA was not significantly different in autophagy proteindeficient and control cells (Fig. 4C and Fig. S4C ). Collectively, these results suggested that the autophagy machinery is required for HCV IRES-dependent translation of the incoming viral RNA, or for delivery of the incoming RNA to the translation apparatus, perhaps by targeting it to the appropriate cellular factor(s) or location.
The Autophagy Machinery Is Required for the Initiation of HCV
Replication But Not to Maintain It. Our results point to a crucial role of the autophagy machinery for translation of incoming viral RNA and the establishment of replication either in HCV RNA transfected cells (Fig. 4 and Fig. S4 ) or in de novo infected cells (Figs. 2 and 3 and Figs. S2 and S3). To determine whether autophagy proteins are required only for initiation of translation and the establishment of HCV replication or if they are also required to maintain ongoing HCV translation and replication, we analyzed the impact of autophagy protein down-regulation on HCV RNA and protein content in stable replicon cells. Whereas Beclin-1 and Atg4B protein content was greatly reduced in shRNA-transduced replicon cells (Fig. 5A) , HCV RNA and protein (illustrated by NS5A expression) levels were unchanged (Fig. 5A) . Similar results were obtained in Huh-7 cells harboring H77 (genotype 1a) and Con1 (genotype 1b) subgenomic replicons or a JFH-1 full-length replicon (Fig. 5A) , suggesting that the autophagy machinery is not required to maintain ongoing HCV replication.
To rule out the possibility that stable replicon cells might be artefactually autophagy-independent because of their prior selection, Beclin-1, Atg4B, and Atg12 were down-regulated in nonselected infected cells virtually all of which were HCV E2 positive (Fig. S4D) . While Beclin-1 and Atg4B expression (Fig.  5B ) and LC3 lipidation (Fig. S4E) were strongly reduced in these cells, intracellular levels of infectious particles and HCV RNA were unchanged (Fig. 5B and Fig. S4E ), confirming that the autophagy machinery is not required to maintain replication of established infection. Furthermore, production of infectious virus particles (Fig. 5B and Fig. S4E) were not significantly reduced in down-regulated cells, confirming that autophagy proteins aren't required for HCV particle secretion (Fig. 3A) .
Collectively, these results indicate that the autophagy machinery is required for translation of incoming RNA and, therefore, HCV replication in de novo infected cells, but not for translation of progeny HCV RNA once replication is established.
Discussion
In this study, we analyzed the impact on HCV infection of several proteins that regulate distinct molecular events leading to autophagy vesicle formation, including its initiation (e.g., Beclin-1), and maturation by the Atg12 (e.g., Atg12 and Atg5) and LC3 (e.g., Atg4B) conjugation systems. We showed that dominant negative inhibition and down-regulation of different regulators of the autophagy pathway strongly suppress productive HCV infection. Our results are in agreement with a recent report suggesting that the down-regulation of LC3 and Atg7, a protein that mediates LC3 lipidation, decreases the HCV RNA content in cells electroporated with JFH-1 HCV RNA (32) . In addition, our results demonstrate that autophagy machinery proteins modulate a post entry-step of HCV infection and, through the analysis of single step infection assays, reveal a functional interaction upstream or at of the level of RNA replication. Consistent with those results, we showed that the autophagy machinery is required for the translation and/or delivery of incoming viral RNA to the translation apparatus and, therefore, for the establishment of productive infection. Importantly, our results demonstrate that autophagy proteins are required for the initiation of HCV RNA translation/replication, but not once these processes are established, indicating that different host factors are required for translation of the incoming viral RNA versus the progeny HCV RNA once replication is established.
Our results indicate that the content of autophagy vesicles is increased in HCV-infected cells, extending recent results obtained in cells infected with the H77 strain of HCV and in cells transfected with JFH1 strain HCV RNA (30, 32) . Sir et al. (32) proposed that the unfolded protein response (UPR) contributes to the induction of autophagy in HCV RNA-transfected cells. However, our results point to a role of autophagy proteins at a very early stage of the HCV life cycle, when HCV proteins are produced from the incoming RNA, which should be independent of the UPR. Interestingly, for other pathogens, pattern recognition receptors (PRR) and the innate signaling pathway have been reported to trigger autophagy in infected cells (4) . Notably, cytosolic RNA-sensing protein kinase PKR and eIF2␣ phosphorylation regulate virus-and starvation-induced autophagy (7, 33) . It is tempting to speculate that recognition of the incoming HCV RNA by RNA-sensing molecules induces autophagy and hence, favors its initial translation. Alternatively, constitutive basal autophagic vesicle formation might be required for initial HCV RNA translation. In this regard, we observed a reduction of LC3 lipidation in Atg12-deficient Huh-7 cells even in the absence of an autophagy inducer (Fig. S2 A) , that was associated with a reduction in susceptibility of these cells to HCV infection. Therefore, it is likely that the establishment of HCV infection depends on the basal level of autophagy rather than its induction.
Formation of a membrane-associated replication complex, composed of viral proteins, replicating RNA and altered cellular membranes, is a hallmark of all positive-strand RNA viruses investigated so far (34) . HCV proteins form a multiprotein complex in an intracellular membrane complex, thought to be derived from ER membranes, which is the site of RNA replication (2, 35) . Interestingly, the viral components of certain positive-strand RNA viruses (e.g., poliovirus, mouse hepatitis virus and dengue virus) that subvert the autophagy machinery for their replication, co-localize with autophagy markers, suggesting that the translation/replication complexes of those viruses might assemble on autophagic vesicles (8, (10) (11) (12) . However, HCV proteins do not colocalize with autophagy proteins in infected cells suggesting that the HCV replication complex does not assemble on autophagic vesicles but rather, that HCV exploits the autophagy pathway by a currently undefined mechanism that appears to be different from other autophagydependent viruses. It is conceivable that the autophagy pathway supports HCV replication by sequestering or destroying HCV replication restriction factor(s). Alternatively, it is tempting to speculate that the autophagy pathway might provide an initial membranous support for translation of incoming RNA, before accumulation of viral proteins and eventual virus-induced cellular modifications. The lack of an effect of autophagy protein down-regulation on previously established HCV replication supports this hypothesis.
How the incoming HCV RNA is targeted to the appropriate cellular factors or location for initial translation remains unknown. It is believed that IRES-mediated HCV genome translation, polyprotein processing and RNA replication occur within ER-derived membranes. Notably, an internal signal sequence located at the C terminus of the core protein targets the nascent polypeptide to the ER membrane for translocation of E1 glycoprotein into the ER lumen (2) . Interestingly, a model of autophagosome maturation from specialized domains of the ER has been proposed (36) (37) (38) . Therefore, the possible continuum between ER and autophagic vesicles and/or autophagy-induced local ER rearrangements, through a dynamic connection between ER and autophagy vesicles (37) , might be of importance, by providing a specialized platform for translation of the incoming HCV RNA.
Materials and Methods
Plasmid and Reagents. The antibodies used for immunoblotting and immunostaining were specific for E2 (C1); NS5A (MS5); Beclin-1 (Santa Cruz Biotechnology); Atg4B (Abcam); LC3 (Novus Biologicals); actin (Sigma Aldrich). Acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN) and thapsigargin (Tg) were purchased from Sigma Aldrich. 2Ј-C-methyladenosine was kindly provided by W. Zhong (Gilead Sciences). The SG and Full-length JFH-1-replicon have been previously described (39) . The subgenomic (SG)-Con1 replicon (S1179I) was kindly provided by C. Rice (Rockefeller University, New York, NY) (40) . The SG-H77 replicon (Htat2ANeo/QR/VI/KR//KR5A/SI) bearing Huh-7 cells were kindly provided by S. Lemon (University of Texas Medical Branch, Galveston, TX) (41). The JFH-1 Rluc/SGR or GND JFH-1 Rluc/SGR plasmids carry bicistronic RNA containing the luciferase reporter gene in the first cistron and wild-type (wt) or replication-deficient (encoding a GDD-to-GND mutation in NS5B) JFH-1 subgenomic replicon in the second cistron, respectively. Lentiviral Particle Production and Huh-7 Cell Transduction. Vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped lentiviral particles were produced in 293T cells by co-transfection of lentiviral vector encoding short hairpin RNAs (shRNAs) (Mission, Sigma Aldrich) with vectors encoding compatible packaging proteins and VSV-G, as described previously (42) . Forty-eight hours posttransfection, cell supernatants were collected, filtrated, and used to transduce Huh-7 cells. Specific shRNA clones were selected according to the target protein down-regulation efficiency and the absence of cytotoxic effects. For all of the experiments displayed, we used freshly shRNA transduced Huh-7 to avoid any compensatory cellular mechanism in autophagy deficient cells that might misleading the interpretation of the results. The sequence of the shRNA are described in SI Text.
Preparation of Viral Stock and Infection. JFH-1 virus was generated by transfection, and viral stocks were produced by infection of Huh-7 cells at a multiplicity of infection (MOI) of 0.01, as described previously (43) . High-titer stocks of cell-culture adapted virus (D183) (29) were prepared by infection of a Huh-7.5.1 cell subclone (clone 2) and used for single step infection experiments (MOI of 10). Cell extracts containing intracellular infectious HCV particles were prepared by 6 freeze-thaw cycles of infected cells as described (39) . Infectivity titers in cell culture supernatants and cell extracts were determined by end-point dilution and E2-specific immunofluorescence as described (43) . Intracellular HCV RNA levels were determined by HCV-specific reverse transcription-real-time quantitative PCR (RT-qPCR) and were normalized for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels as described (43) .
Production of HCVpp and Cell Entry Assays. Viral pseudoparticles named HCVpp and VSV-Gpp harbored the glycoproteins of HCV and VSV-G, respectively, and were produced by transfection in 293T cells of vectors encoding viral glycoproteins, packaging proteins, and GFP-transfer vector. For infection assays, target cells were seeded 24 h before inoculation at an MOI of 0.1. Then medium was removed and dilutions of viral supernatants were added to the cells and incubated for 4 h. Supernatants were then removed and the infected cells kept in regular medium (DMEM, 10% FCS) for 72 h before analysis of the percentage of GFP-positive cells by FACS analysis.
Reporter Replicon Replication Assays. In vitro transcribed RNAs were introduced into Huh-7 cells by electroporation as described in SI Text. RNA transfection efficiency and cell viability were assessed by measuring the intracellular neo/SGR RNA content 6 h posttransfection and by determining cell densities posttransfection in the absence of selection, respectively. For renilla luciferase assay (wt and GND mutant Rluc/SGR), cells were lysed with cell culture lysis buffer (Promega). Lysates were harvested and mixed with luciferase assay substrate (Promega), as suggested by the manufacturer. RLU values were normalized to the number of viable cells for each sample determined by a trypan blue staining. Cell viability was confirmed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assays.
